Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease (STOPCLD)

as vehicle would facilitate its delivery to the periphery of the lung and would inhibit lung inflammation and mitigate acute lung injury.

  • 0 views
  • 14 May, 2022
  • 1 location
Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free

The purpose of the study is to pilot test a multi-modal smoking cessation and relapse prevention intervention with the lung cancer patient population and to obtain preliminary data on its

  • 0 views
  • 11 May, 2022
  • 1 location
EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer

This study is a single-arm, open, exploratory clinical study to evaluate the safety and efficacy of EGFR/B7H3 CAR-T in patients with EGFR/ B7H3-positive advanced solid tumors (lung cancer and

  • 0 views
  • 28 Apr, 2022
  • 1 location
A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 Mutations (PINNACLE)

The primary purpose of this study is to compare the progression-free survival (PFS) in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring human

  • 0 views
  • 23 May, 2022
  • 1 location
Furmonertinib in First-line Treatment of Patients With CNS Metastatic EGFR Mutation Positive NSCLC

EGFR mutation positive advanced NSCLC patients with CNS metastases have poor prognosis, second-line furmonertinib dose at 160mg level in EGRF T790M mutation positive CNS metastatic NSCLC have provided relevant benefit with a high CNS PFS and CNS ORR. Whether CNS metastatic EGFR mutation positive NSCLC patients can benefit from first-line …

  • 0 views
  • 23 May, 2022
  • 1 location
  • 0 views
  • 09 May, 2022
Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy (NeoP)

A phase II, single-arm, open-label study evaluating feasibility, safety and efficacy of combined chemotherapy and pembrolizumab as neoadjuvant/adjuvant therapy in stage IIa-IIIB NSCLC adult patients followed by adjuvant PD-(L)1 inhibitor treatment for up to 1 year

  • 0 views
  • 23 May, 2022
  • 1 location
High Flow Nasal Oxygenation Versus Non-invasive Ventilation for Patients With Blunt Chest Trauma

Chest trauma remains an issue for health services for both severe and apparently mild trauma management. Severe chest trauma is associated with high mortality and is liable for 25% of mortality in multiple traumas. Moreover, mild trauma is also associated with significant morbidity, especially in patients with preexisting conditions. Thus, …

  • 0 views
  • 28 Apr, 2022
  • 1 location
NUTRITIONAL ASSESSMENT IN NON-TUBERCULOUS MYCOBACTERIA PULMONARY DISEASE (nutriNTM)

Non-tuberculous mycobacterial (NTM) pulmonary disease (PD) is an emerging condition with heterogeneous manifestations from both the microbiological and the clinical point of view. Diagnostic and

  • 0 views
  • 25 May, 2022
  • 1 location
Virtual Bronchoscopic Navigation to Increase Diagnostic Yield in Patients With Pulmonary Nodules (NAVIGATOR)

Background Transthoracic computed tomography (CT)-guided procedures are the current gold Standard for obtaining diagnostic biopsies of solitary pulmonary nodules (SPN) in the peripheral lung

  • 0 views
  • 24 May, 2022
  • 1 location